Articles
Editor’s foreword
Welcome to the February 2026 edition of the JVSGBI. We have two editorials in this issue, the first editorial is the third of a series by Long and co-authors outlining approaches to ensure mentorship is efficient, effective and meaningful with specific reference to the recently launched VSGBI mentorship programme for newly appointed vascular surgical consultants.…
Making mentorship meaningful: a closer look at the mentoring journey
Introduction Previous editorials set out the rationale for introducing mentorship within UK vascular surgery and provided a high-level overview of what to expect from the VSGBI mentorship programme.1,2 As the first cohort begins its mentoring journey, this issue turns its attention to the mentoring relationship itself: how it develops, what sustains it and how it…
Improving vascular referral coordination through live documentation in a hub-and-spoke system
Introduction Over the past two decades there has been a clear trend in the UK National Health Service (NHS) towards the centralisation of hospital services. In vascular surgery this model typically consists of a central hub for surgical interventions and multiple spoke sites that provide outpatient follow-up and some minor procedures, such as varicose vein…
A national UK-wide survey of tranexamic acid use in vascular surgery
Introduction Tranexamic acid (TXA) is a synthetic lysine analogue that inhibits fibrinolysis and reduces surgical bleeding by stabilising clot formation.1 Large randomised trials have demonstrated its efficacy in a range of clinical settings including trauma, postpartum haemorrhage and cardiac surgery, where TXA has been associated with reductions in mortality, critical bleeding and transfusion requirements.2-5 National…
